Course and outcome of hepatitis C (Q29620057)

Europe PubMed Central

title

Course and outcome of hepatitis C (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407573

30 April 2017

1 reference

Hoofnagle JH

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407573

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407573

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

November 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407573

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407573

30 April 2017

volume

36

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407573

30 April 2017

issue

5 Suppl 1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407573

30 April 2017

page(s)

S21-9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407573

Hepatitis C virus infection

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

The molecular virology of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Genotypic analysis of hepatitis C virus in American patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Perspectives for a vaccine against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Efficient initiation of HCV RNA replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Protection against persistence of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Early events in hepatitis C virus infection of chimpanzees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Determinants of viral clearance and persistence during acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Hepatitis C virus-associated fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Spontaneous negativation of serum hepatitis C virus RNA is a rare event in type C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Hepatitis C: the clinical spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

The spectrum of liver disease in the general population: lesson from the Dionysos study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Loss of circulating hepatitis C virus in children who developed a persistent carrier state after mother-to-baby transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Hepatitis C in African Americans: summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

A role for hepatitis C virus infection in type II cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Hepatitis C virus infection in patients with essential mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Clinical and histopathologic analysis of the relationship between lichen planus and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Neurological manifestations of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36227

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36227

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407573

30 April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407573

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017